These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 14361698)
1. MDAA chapters and the patient service program. ABRAMSON AS Am J Phys Med; 1955 Feb; 34(1):257. PubMed ID: 14361698 [No Abstract] [Full Text] [Related]
2. SYMPOSIUM: muscular dystrophy: MDAA chapters and the patient service program. Am J Phys Med; 1955 Feb; 34(1):257-73; discussion 274-8. PubMed ID: 14361697 [No Abstract] [Full Text] [Related]
3. Community services in the patient service program. BURKE VM Am J Phys Med; 1955 Feb; 34(1):269-73. PubMed ID: 14361701 [No Abstract] [Full Text] [Related]
4. The need for patient service programs in muscular dystrophy. SCHWEITZER MD Am J Phys Med; 1955 Feb; 34(1):265-8. PubMed ID: 14361700 [No Abstract] [Full Text] [Related]
7. Muscular dystrophy in South Florida. BURCH JE; POLLEN W; SAMARTINO GT J Fla Med Assoc; 1955 Mar; 41(9):713-7. PubMed ID: 14354123 [No Abstract] [Full Text] [Related]
8. [Methylandrostenediol (neosteron) in the treatment of progressive muscular dystrophy]. BEKENY G; KRAFT F; LANG S Orv Hetil; 1955 Feb; 96(8):211-2. PubMed ID: 14384301 [No Abstract] [Full Text] [Related]
9. [Treatment of progressive muscular dystrophy with adenosintriphosphoric acid]. MAN'KOVSKII BN; SLONIMSKAIA VM Zh Nevropatol Psikhiatr Im S S Korsakova; 1955 Jan; 55(1):43-7. PubMed ID: 14375308 [No Abstract] [Full Text] [Related]
10. The congenital and limb-girdle muscular dystrophies: sharpening the focus, blurring the boundaries. Kirschner J; Bönnemann CG Arch Neurol; 2004 Feb; 61(2):189-99. PubMed ID: 14967765 [TBL] [Abstract][Full Text] [Related]
11. Gradients of functional ability of importance in rehabilitation of patients with progressive muscular and neuromuscular diseases. SWINYARD CA; DEAVER GG; GREENSPAN L Arch Phys Med Rehabil; 1957 Sep; 38(9):574-9. PubMed ID: 13459572 [No Abstract] [Full Text] [Related]
12. Treatments for muscular dystrophy: increased treatment options for Duchenne and related muscular dystropies. Wells DJ Gene Ther; 2008 Aug; 15(15):1077-8. PubMed ID: 18528429 [No Abstract] [Full Text] [Related]
13. Assessment of drugs for therapeutic efficacy. TRAVELL J Am J Phys Med; 1955 Feb; 34(1):129-40. PubMed ID: 14361682 [No Abstract] [Full Text] [Related]
14. Gene therapy for muscular dystrophy reaches human clinical trial. Clemens PR; Eghtesad S; Reay DP Ann Neurol; 2009 Sep; 66(3):267-70. PubMed ID: 19798643 [No Abstract] [Full Text] [Related]
15. Gene therapy for muscular disease. Johnston N Drug Discov Today; 2004 Sep; 9(18):777. PubMed ID: 15364061 [No Abstract] [Full Text] [Related]
16. [Updates in muscular dystrophies]. Erazo-Torricelli R Rev Neurol; 2004 Nov 1-15; 39(9):860-71. PubMed ID: 15543503 [TBL] [Abstract][Full Text] [Related]
17. Tracheobroncial haemorrage in patients with neuromuscular disorders by Francesca Iodice, MD. Markstrom A; Andersson G Respir Med; 2005 Dec; 99(12):1616. PubMed ID: 16019197 [No Abstract] [Full Text] [Related]
18. New gene therapy technique shows some muscle. Schub T Lab Anim (NY); 2004 Sep; 33(8):8-9. PubMed ID: 15334094 [No Abstract] [Full Text] [Related]